CVE-2016-8358An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1.
Updated under an hour ago ()
Does this affect you?
It affects smiths-medical cadd-solis_medication_safety_software. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.50%, higher than 41% of scored CVEs.
Do this next
Free account, 1 product
An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. The affected software does not verify the identities at communication endpoints, which may allow a man-in-the-middle attacker to gain access to the communication channel between endpoints.
- CVSS
- 8.5 HIGH (v3.0, NVD)CVSS:3.0/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:H
- Weakness (CWE)
- Not given
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.50% (percentile 41)
- Assigned by
- icscert
- NVD analysis
- Modified
- Record last updated
- Aug 6, 2024
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
smiths-medical cadd-solis_medication_safety_software smiths-medical:cadd-solis_medication_safety_software | 1.0; 2.0; 3.0; 3.1 | NVD |
References
- https://ics-cert.us-cert.gov/advisories/ICSMA-16-306-01x-refsource-misc, third-party-advisory, us-government-resource
- http://www.securityfocus.com/bid/94630vdb-entry, x-refsource-bid, third-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.